In vitrosusceptibility testing inAspergillusspecies: an update

Comparison of Disk Diffusion, E-Test and Broth Microdilution Test in Determination of Susceptibility ofAspergillusSpecies to Amphotericin B, Itraconazole and Voriconazole

(2014) A. Ozkutuk et al.   JOURNAL OF CHEMOTHERAPY

Species Identification and Antifungal Susceptibility Patterns of Species Belonging to Aspergillus Section Nigri

(2009) L. Alcazar-Fuoli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus

(2009) J. Meletiadis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azole‐Resistant Central Nervous System Aspergillosis

(2009) Jan W. M. van der Linden et al.   CLINICAL INFECTIOUS DISEASES

Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints

(2009) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

Triazole-resistant candidaemia following posaconazole exposure

(2009) Stefan Weiler et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Caspofungin Etest Endpoint for Aspergillus Isolates Shows Poor Agreement with the Reference Minimum Effective Concentration

(2009) J. Fuller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network

(2009) J. W. Baddley et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma

(2009) Bahrie Bellete et al.   MEDICAL MYCOLOGY

The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus

(2009) Wendy Sande et al.   MEDICAL MYCOLOGY

What is a species inAspergillus?

(2009) R. A. Samson et al.   MEDICAL MYCOLOGY

In vitro susceptibility testing in fungi: a global perspective on a variety of methods

(2009) Cornelia Lass-Flörl et al.   MYCOSES

Antifungal Activity of Caspofungin in Combination with Amphotericin B against Candida glabrata: Comparison of Disk Diffusion, Etest, and Time-Kill Methods

(2008) N. Kiraz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activities of Various Antifungal Drugs against Aspergillus terreus: Global Assessment Using the Methodology of the European Committee on Antimicrobial Susceptibility Testing

(2008) C. Lass-Florl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Susceptibility Testing of Anidulafungin and Voriconazole Alone and in Combination against Conidia and Hyphae of Aspergillus spp. under Hypoxic Conditions

(2008) S. Perkhofer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins

(2008) M. C. Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing

(2008) M. C. Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species

(2008) J. Guinea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus

(2008) J. L. Rodriguez-Tudela et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potential Basis for Amphotericin B Resistance in Aspergillus terreus

(2008) G. Blum et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

(2008) D. Neofytos et al.   CLINICAL INFECTIOUS DISEASES

First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation

(2008) Jutta Auberger et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption

(2008) R. Araujo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Multiple-azole-resistantAspergillus fumigatusosteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery

(2008) Caspar J. Hodiamont et al.   MEDICAL MYCOLOGY

In vitrosusceptibility-testing inAspergillusspecies

(2008) Cornelia Lass-Flörl et al.   MYCOSES

Outwitting Multidrug Resistance to Antifungals

(2008) B. C. Monk et al.   SCIENCE

Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism

(2008) Eveline Snelders et al.   PLOS MEDICINE